Table 3.
Gene expression in DPSCs at day 14 of exposure to ODM and low and high doses of Metformin
| RUNX2 (FC) | ODM | Metformin 500 µM |
Metformin 1000 µM |
p-value |
|---|---|---|---|---|
| 0.97 ± 0.16b | 3.47 ± 0.42 a/c | 1.13 ± 0.16/b | 0.0001 | |
| DMP1 (FC) | 1.07 ± 0.18b | 3.23 ± 0.32a/c | 1.20 ± 0.21b | 0.0001 |
| BMP2 (FC) | 1.10 ± 0.18b | 3.68 ± 0.48a/c | 1.14 ± 0.13a/b | 0.0001 |
Mean ± SD values of ALP activity at day 3 and day 7 are presented for all experimental groups. One-way ANOVA showed significant differences across groups at both time points (p = 0.0001)
Superscript letters denote statistically significant pairwise comparisons versus ODM (a), low dose of Metformin (b), and high dose of Metformin (c)
Abbreviations: ODM Osteogenic differentiation medium, DPSCs Dental pulp-derived mesenchymal stem cells, ODM Osteogenic differentiation medium, RUNX2 Runt-related transcription factor 2, DMP1 Dentin matrix acidic phosphoprotein 2, BMP2 Bone morphogenetic protein 1, FC Fold change